We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Stand-Alone AI Technology Reduces Radiologists’ Screening Mammography Workloads by 90%

By MedImaging International staff writers
Posted on 20 Dec 2021
Print article
Illustration
Illustration

The use of artificial intelligence (AI) as a stand-alone reader for digital mammography (DM) or digital breast tomosynthesis (DBT) breast screening could ease radiologists’ workload while maintaining quality, according to new research.

Researchers from the Hospital Universitario Reina Sofía (Cordova, Spain) conducted a study to retrospectively evaluate the stand-alone performance of an AI system as an independent reader of DM and DBT screening examinations. Consecutive screening-paired and independently read DM and DBT images were collected and an AI system computed a cancer risk score (range, 1–100) for the DM and DBT examinations independently. AI stand-alone performance was measured using the area under the receiver operating characteristic curve (AUC) and sensitivity and recall rate at different operating points selected to have non-inferior sensitivity compared with the human readings (non-inferiority margin, 5%). The recall rate of AI and the human readings were compared using a McNemar test.

A total of 15 999 DM and DBT examinations (113 breast cancers, including 98 screen-detected and 15 interval cancers) from 15 998 women were evaluated. AI achieved an AUC of 0.93 (95% CI: 0.89, 0.96) for DM and 0.94 (95% CI: 0.91, 0.97) for DBT. For DM, AI achieved non-inferior sensitivity as a single (58.4%; 66 of 113; 95% CI: 49.2, 67.1) or double (67.3%; 76 of 113; 95% CI: 58.2, 75.2) reader, with a reduction in recall rate (P < .001) of up to 2% (95% CI: −2.4, −1.6). For DBT, AI achieved non-inferior sensitivity as a single (77%; 87 of 113; 95% CI: 68.4, 83.8) or double (81.4%; 92 of 113; 95% CI: 73.3, 87.5) reader, but with a higher recall rate (P < .001) of up to 12.3% (95% CI: 11.7, 12.9).

The researchers concluded that AI could replace radiologists’ readings in breast screening, achieving a non-inferior sensitivity, with a lower recall rate for DM but a higher recall rate for DBM.

Related Links:
Hospital Universitario Reina Sofía 


Print article
Sun Nuclear -    Mirion
CIRS -  MIRION

Channels

Radiography

view channel
Image: The FDA has cleared the CSA system with Dynamic Digital Radiography (Photo courtesy of 20/20 Imaging)

Advanced Digital X-Ray System Allows Clinicians to Capture and Visualize Anatomy in Motion

Dynamic Digital Radiography (DDR) is a revolutionary X-ray technology that enables the visualization of anatomy in motion, so clinicians can interpret the dynamic interaction of anatomical structures,... Read more

Ultrasound

view channel
Image: EG-740UT ultrasound endoscope combined with ARIETTA 850 provides outstanding ultrasound image quality (Photo courtesy of FUJIFILM)

Next-Gen Ultrasound Endoscope Enables Complex Diagnostic and Therapeutic Procedures

Endoscopic ultrasound is a specialist procedure performed utilizing an endoscope equipped with an ultrasonic transducer which emits and receives ultrasonic waves within the gastrointestinal tract, such... Read more

Imaging IT

view channel
Illustration

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.